echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Chinese scientists have made new progress in the field of polysaccharose vaccine research

    Chinese scientists have made new progress in the field of polysaccharose vaccine research

    • Last Update: 2021-01-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    News Agency, Chongqing, January 10 (Reporter Ke Gaoyang) Vaccination is an effective measure to prevent the epidemic of infectious diseases, polysaccharose vaccine is one of the common types of vaccines. Chinese researchers have recently made new progress in the field of polysaccharide vaccine research and developed an oral polysaccharide vaccine for the prevention of Streptococcus pneumoniae infection. The research results have been published online in the international
    Journal of the American Academy of Sciences.
    , author of the paper and professor of animal medicine at Southwest University, said Streptococcus pneumoniae is one of the main causes of pneumonia and other conditions, with a high fatality rate. At present, it is commonly used to prevent Streptococcus pneumoniae infection is a multi-priced polysaccharide vaccine, but the production process of this kind of vaccine is more complex, the price is higher, the immune effect is not ideal.
    In response to these problems, Kong Qingke led the research team on zoonotic infectious diseases found that the use of anti-venom salmonella as a carrier of multi-sugar vaccine delivery, can induce the host to produce specific polysaccharide mucosa, body fluid and cellular immune response and long-term immune memory. On this basis, the team developed an oral polysaccharide vaccine that can be used to prevent Streptococcus pneumoniae infection, which is more convenient and less costly than traditional intramuscular vaccines.
    U.S.
    Roy Curtis believes that this study breaks through the current traditional bacterial polysaccharide vaccine construction, but also can be applied to other pathogen sources of polysaccharide vaccine, protein vaccine and other vaccine types, help to achieve rapid and efficient vaccine construction, improve the prevention of sudden infectious diseases.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.